Associate Director, Office of Biostatistics and Epidemiology, CBER, FDA
Mr. Martin Ho is Associate Director of Quantitative Patient Inputs & Real-World Patient Evidence at Office of Biostatistics & Epidemiology, CBER, US FDA. Prior, he was the Director of Quantitative Innovation at Center for Devices, turning new data sources into regulatory-grade evidence...
Read More →
Senior Scientist, Biostatistics, Merck & Co., Inc.
Thomas Jemielita is a senior scientist in Early Development Statistics (EDS) within BARDS at Merck & Co., Inc., currently providing statistical support for various early oncology trials. Prior to joining Merck in 2017, Thomas received his PhD in Biostatistics from the University of...
Read More →TG
Division Director, Division of Biometrics IX, OTS, CDER, FDA
Thomas E. Gwise, Ph.D. is the Director of the Division of Biometrics IX. The Division, which is part of the Offices of Translational Science and Biostatistics in FDA’s Center for Drug Evaluation and Research, provides statistical expertise to the Office of New Drugs and the Oncology...
Read More →
Mathematical Statistician, OB, OTS, CDER, FDA